Accessibility Menu
Vycor Medical logo

Vycor Medical(OTC) VYCO

Market Cap$2.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-49%
1 Year-47%
1 Month-1%
$0.07
+21.05%
+0.01Today
Vycor Medical last closing stock price
MetricPriceDate
Last closeUSD 0.072026-07-13
Vycor Medical stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.75%USD 0.062026-07-02
1 month-1.15%USD 0.072026-06-10
3 month-1.29%USD 0.072026-04-14
Year to date-42.98%USD 0.122025-12-31
1 year-46.51%USD 0.132025-07-10
3 year-28.12%USD 0.102023-07-13
5 year-49.23%USD 0.142021-07-14
Since inception-99.86%USD 51.002009-03-31

Vycor Medical Financials at a Glance

Market Cap

$2.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.89M

Net Income (TTM)

-$13.76K

EPS (TTM)

-$0.01

P/E Ratio

-6.76

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$0.07

Volume

2,000

Open

$0.06

Previous Close

$0.07

Daily Range

$0.06 - $0.07

52-Week Range

$0.03 - $0.20

Estimated Earnings Date

May 13, 2026

VYCO News

Foolcom-Featured.png

Vycor Medical Posts 22 Percent Q2 Growth

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vycor Medical

Vycor Medical creates devices for brain surgery and vision rehabilitation. Its products help surgeons access the brain safely and support stroke patients with vision loss. Hospitals and patients use these tools to improve treatment and recovery outcomes.

Products and Services

  • Neurosurgery Devices (96.4% of revenue): ViewSite Brain Access System helps surgeons reach brain areas with less tissue damage.
  • Vision Rehabilitation (3.6% of revenue): NovaVision offers computer-based therapy for people with vision loss after stroke or brain injury.
  • Eye Movement Training: NeuroEyeCoach software trains patients to improve eye movement after brain injury.
  • Direct and Distributor Sales: Sells directly to U.S. hospitals and through partners in Europe.
  • Licensing Agreements: Partners like HelferApp GmbH distribute NovaVision products in Austria and Switzerland.

Growth and Expansion

  • Signed a license and transition agreement with HelferApp GmbH in 2024 for Austria and Switzerland.
  • Engaged Maxim Group LLC in August 2024 to explore acquisitions and partnerships.
  • Continued development of new products and enhancements to the ViewSite Brain Access System since 2023.
  • Focused on digital health delivery and licensing for NovaVision therapies since 2024.

What Makes Vycor Medical Stand Out

Vycor Medical focuses on minimally invasive solutions for brain surgery and digital therapies for vision loss. Its products hold multiple regulatory approvals, supporting use in the U.S. and Europe. The company leverages partnerships and digital platforms to reach hospitals and patients efficiently.

Five Things You Need to Know

  • Revenue was $1.86 million in 2025, up approximately 17.2% from 2024.
  • Vycor Medical segment made up 96.4% of 2025 revenue.
  • Gross profit margin was 83.8% in 2025, down from 89% in 2024.
  • Net loss was $72,426 in 2025, improved from $107,200 in 2024.
  • Working capital deficit was $4.2 million at December 31, 2025.

Bottom Line

Vycor Medical has evolved by focusing on specialized neurosurgery devices and digital vision therapies. The company adapts through partnerships, product development, and targeted market expansion.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

7

CEO

Peter C. Zachariou

Website

www.vycormedical.com

Headquarters

Boca Raton, FL 33487, US

VYCO Financials

Key Financial Metrics (TTM)

Gross Margin

82.93%

Operating Margin

4.91%

Net Income Margin

-0.73%

Return on Equity

0.34%

Return on Capital

N/A

Return on Assets

-1.61%

Earnings Yield

-14.79%

Dividend Yield

0.00%

Payout Ratio

-23.58%

Stock Overview

Market Cap

$2.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

33.37M

Volume

2.00K

Avg. Volume

2.18K

Financials (TTM)

Gross Profit

$1.56M

Operating Income

$92.51K

EBITDA

$139.83K

Operating Cash Flow

$112.86K

Capital Expenditure

-$5.22K

Free Cash Flow

$107.63K

Cash & ST Invst.

$173.63K

Total Debt

$980.81K

Vycor Medical Performance Analysis

Vycor Medical annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,222,989-12.2%
20232023-12-31USD 1,460,60419.4%
20242024-12-31USD 1,589,3248.8%
20252025-12-31USD 1,863,40017.2%
Vycor Medical sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3013.7%
Q32025-09-303.5%
Q42025-12-31-18.9%
Q12026-03-3110.0%
Vycor Medical annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.02-10.2%
20232023-12-31USD -0.01-47.4%
20242024-12-31USD -0.018.3%
20252025-12-31USD -0.01-9.2%
Vycor Medical sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30150.0%
Q32025-09-30-883.3%
Q42025-12-31166.0%
Q12026-03-31-80.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$458.54K

+5.1%

Gross Profit

$361.17K

+0.7%

Gross Margin

78.77%

N/A

Market Cap

$2.30MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$328.96K

N/A

Employees

7

N/A

Net Income

$20.11K

+152.1%

EBITDA

$61.48K

+1760.1%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$173.63K

+184.4%

Total Debt

$980.81K

-4.6%

Accounts Receivable

$194.04K

-15.4%

Inventory

$181.91K

+3.1%

Long Term Debt

$134.98K

-24.2%

Short Term Debt

$845.83K

-0.5%

Return on Assets

-1.61%

N/A

Return on Invested Capital

-2.26%

N/A

Free Cash Flow

$99.42K

+469.5%

Operating Cash Flow

$99.42K

+469.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TBRIFTherma Bright Inc.
$0.04+0.00%
LIFDLFTD Partners Inc.
$0.20+0.00%
TDSGFTelo Genomics Corp.
$0.03-3.13%
FZMDFuse Medical, Inc.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
NOKNokia
$8.41-0.06%
SKHYSK Hynix
$126.79-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About VYCO

What is the current price of Vycor Medical?

Vycor Medical is trading at $0.07 per share.

What is the 52-week range for Vycor Medical?

Over the past 52 weeks, Vycor Medical has traded between $0.03 and $0.20.

How much debt does Vycor Medical have?

As of the most recent reporting period, Vycor Medical reported total debt of $980.81K.

How much cash does Vycor Medical have on hand?

Vycor Medical reported $173.63K in cash and cash equivalents in its most recent financial results.

What is Vycor Medical’s dividend yield?

Vycor Medical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services